Quick Discovery
Our People
The Drug Discovery Unit attracts expertise from across the biopharmaceutical industry and academia. Our dynamic team is made up of over 100 highly skilled, experienced scientists from both academic and pharmaceutical industry backgrounds, with a professional, pioneering approach to our work.
Combined with our outstanding facilities, this has created a unique environment for industry ready drug discovery research within an academic environment.
Senior Leadership Team

TBA
Head of the Drug Discovery Unit

Professor Ian Gilbert FRSC
Interim Head of the DDU and Head of Medicinal Chemistry

Professor Kevin Read
Head of Drug Metabolism and Pharmacokinetics

Professor David Gray
Head of Biology and Portfolio Manager for Innovative Targets Portfolio

TBA
Head of Business Development

Dr Manu De Rycker
Head of Translational Parasitology and Portfolio Leader for Kinetoplastids

Dr Catharine Goddard
WCAIR Centre Manager

Louise Burns
Finance Business Partner
Extended Leadership Team

Dr Beatriz Baragana
Apicomplexan Portfolio Manager

Dr Laura Cleghorn
TB Portfolio Manager

TBA
Coronavirus Portfolio Manager

Dr Fabio Zuccotto
Head of Computational Chemistry

Dr Vincent Postis
Molecular Interaction Team Leader

Dr Gary Tarver
Synthetic Methodologies Team Leader
Founders

Professor Mike Ferguson
Founder of the Drug Discovery Unit
